Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: Comparison with enhanced CT

British Journal of Radiology

Volumn 85, Issue 1014, 2012, Pages 745-752

  Tokunaga, S ^a   Koda, Masahiko ^a   Matono, T ^a   Sugihara, T ^a   Nagahara, T ^a   Ueki, M ^a   Murawaki, Y ^a   Kakite, S ^a   Yamashita, E ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FERUCARBOTRAN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CANCER; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOFREQUENCY ABLATION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONTRAST MEDIA; DEXTRANS; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84861596727     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/64518148     Document Type: Article

References (25)

1. Schwarz RE, Smith DD. Trends in local therapy for hepatocellular carcinoma and survival outcomes in the US population. Am J Surg 2008;195:829-36. (Pubitemid 351749460)
2. Garrean S, Hering J, Saied A, Helton WS, Espat NJ. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 2008;195:508-20. (Pubitemid 351417476)
3. Ng KK, Poon RT, Lo C-M, Yuen J, Tso WK, Fan S-T. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 2008;12:183-91.
4. Vossen JA, Buijs M, Kamel IR. Assessment of tumor response on MR imaging after locoregional therapy. Tech Vasc Intervent Radiol 2006;9:125-32. (Pubitemid 46875018)
5. Park M-H, Rhim H, Kim Y-S, Choi D, Lim HK, Lee WF. Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics 2008;28:379-92.
6. Okusaka T, Okada S, Ueno H, Ikeda M, Shimada K, Yamamoto J, et al. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathological features. Cancer 2002;95:1931-7. (Pubitemid 35222173)
7. Ikeda K, Seki T, Umehara H, Inokuchi R, Tamai T, Sakaida N, et al. Clinicopathological study of small hepatocellular carcinoma with microscopic satellite nodules to determine the extent of tumor ablation by local therapy. Int J Oncol 2007;31:485-91.
8. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation. Multivariate meta-analysis and review of contributing factors. Ann Surg 2005;242:158-71. (Pubitemid 41033431)
9. Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, et al. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Jpn J Clin Oncol 2007;37:658-72. (Pubitemid 47617785)
10. Peng Z-W, Zhang Y-J, Chen M-S, Liang H-H, Li J-Q, Zhang Y-Q, et al. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Surg Oncol 2008;17:23-31. (Pubitemid 351200024)
11. Mori K, Fukuda K, Asaoka H, Ueda T, Kunimatsu A, Okamoto Y, et al. Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran-feasibility study. Radiology 2009;251:557-65.
12. Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988;168:297-301.
13. Tsuda M, Majima K, Yamada T, Saitou H, Ishibashi T, Takahashi S. Hepatocellular carcinoma after radiofrequency ablation therapy dynamic CT evaluation of treatment. J Clin Imaging 2001;25:409-15. (Pubitemid 33081117)
14. Smith S, Gillams A. Imaging appearances following thermal ablation. Clin Radiol 2008;63:1-11. (Pubitemid 350212856)
15. Nishijima N, Ohsaki Y, Kita R, Esoh Y, Yamanaka S, Kawakami H, et al. Proposal of the radicality grading as a criterion for therapeutic effectiveness of RFA against hepatocellular carcinoma, in relation to the local recurrence rate. Kanzo 2008;49:192-9.
16. Wen YL, Kudo M, Zheng RQ, Minami Y, Chung H, Suetomi Y, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR AmJ Roentgenol 2003;181:57-63. (Pubitemid 36741461)
17. Koda M, Mandai M, Matono T, Sugihara T, Nagahara T, Ueki M, et al. Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography: comparison with virtual sonography with magnetic navigation. Clin Imaging 2010;34:60-4.
18. Hamm B, Staks T, Taupitz M, Maibauer R, Speidel A, Huppertz A, et al. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. J Magn Reson Imaging 1994;4: 659-68.
19. Liu K, He X, Lei X-Z, Zhao L-S, Tang H, Liu L, et al. Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma. World J Gastroenterol 2003;9:1946-9. (Pubitemid 37168418)
20. Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000;32:205-12. (Pubitemid 30614651)
21. Tanimoto A, Oshio K, Suematsu M, Pouliquen D, Stark DD. Relaxation effects of clustered particles. J Magn Reson Imaging 2001;14:72-7.
22. Sartori S, Tombesi P, Macario F, Nielsen I, Tassinari D, Catellani M, et al. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Radiology 2008;248:670-9.
23. Kim Y-S, Rhim H, Cho OK, Koh BH, Kim Y. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol 2006;59:432-41. (Pubitemid 44301741)
24. Rhim H, Lim HK, Kim Y-S, Choi D, Lee WJ. Radiofrequency ablation of hepatic tumors: lessons learned from 3000 procedures. J Gastroenterol Hepatol 2008;23:1492-500.
25. Livraghi T, Goldberg SN, Meloni F, Solbiati L, Gazelle GS. Hepatocellular carcinoma: comparison of efficacy between percutaneous ethanol injection and radiofrequency. Radiology 1999;210:655-63.